DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/wgtqld/global_api_market) has announced the addition of the "Global API Market Outlook 2018" report to their offering.
The recent spurt in emerging markets has directly impacted the pharmaceutical industry. Rising affordability, enhanced life expectancy and improved standard of living are all providing impetus to the demand for pharmaceuticals. However, major regulatory changes in the United States and Europe along with rising labor costs in China are set to change the API landscape. As patterns in developed regions continue to remain flat and opportunities for growth shift from traditional markets, the API industry is expected to witness the rise of second wave emerging markets in countries such as Brazil, Mexico, South Korea and Taiwan.
According to the report, Global API Market Outlook 2018, in the wake of the above developments, the Global API industry is expected to grow at a CAGR of 9.4% from 2013-2018. The market has been divided into four major geographies which comprise Americas, Asia, Europe and the rest of the world. For every region, a current and future outlook of the API industry has been provided. We have also deduced a list of top countries which will be responsible for the majority of API related activities. These countries include the likes of US, Italy, Japan, China, India and South Korea. For every such country a current and future outlook of the API industry has been presented along with the regulatory scenario pertaining to API manufacturing and trade. A future opportunity assessment of every region has also been done to help highlight the areas that have promising possibilities.
As the days of the blockbuster drugs start waning, more flexible manufacturing focused on personalized medicines can be seen as the future of the pharmaceutical business. The report elaborates on the rise of more such trends and challenges and their possible impacts on the industry.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. APIs - An Introduction
5. Countries' Comparative Analysis: API Manufacturing
6. Key Geographical Markets
7. Major Countries and their Regulatory Scenario
8. Analysis by Therapeutic Segments
9. Trends & Challenges
10. Competitive Landscape
- Aurobindo Pharma Limited
- Boehringer Ingelheim GmbH
- Cambrex Corporation
- Divis Laboratories Limited
- Pfizer CentreSource
- Royal DSM
- BASF SE
- Dr Reddy's Laboratories
- Fabbrica Italiana Sintetici
- Kyowa Hakko Kirin
- North China Pharmaceutical Group Corporation
- Northeast Pharmaceutical Group
- Teva Active Pharmaceutical Ingredients
- Zhejiang Hisun Pharmaceutical Co. Ltd.
For more information visit http://www.researchandmarkets.com/research/wgtqld/global_api_market